期刊文献+

大孔吸附树脂分离富集土贝母总皂苷的研究 被引量:8

Isolation and purification of total tubeimosides from Bolbostemma paniculatum by macroporous resin
下载PDF
导出
摘要 目的:优化大孔吸附树脂分离纯化土贝母总皂苷的工艺条件。方法:以土贝母总皂苷的吸附量和解吸率为指标,大范围筛选树脂,并通过单因素试验、正交试验及方差分析确定了土贝母总苷分离富集的优选操作条件。结果:NKA树脂具有较好的吸附性能和解吸效果;优选吸附条件为上样含生药量30mg·mL-1,树脂色谱柱的径高比1∶7,药材∶树脂为1∶4;吸附完全后,先以水洗脱,除去杂质,再以80%乙醇洗脱,可以得到纯度较好的土贝母总苷。结论:NKA树脂对土贝母总苷的吸附量大,解吸容易,确定的吸附与洗脱条件简单可行,所得产品的色泽好、纯度高,此工艺具有良好的产业化前景。 Objective: To select the optimum purification process of all tubeimoisides from Bolbostemma paniculatum by macroporous resin. Static absorption test and deabsorption test were carried out to screen the best macroporous resin for all tubeimosides. The single factor test, orthogonal experimental designs and variance analysis were applied to optimize the manipulation parameters of macroporous resin. Result: The macroporous resin NKA possessed the strongest absorption ability to all tubeimosides among the 9 resins studied, in addition to an easy de-absorption property. The optimum absorption conditons were A_(2)B_(3)C_(1), namely concentration of feede 30 mg·mL^(-1), diameter: height of the chromatography column 1∶7. the weight ratio of raw material and resins 1∶2. Conclusion: The above experimental results can provide experimental basis for large-scale purification process of all tubeimosides.
出处 《中国中药杂志》 CAS CSCD 北大核心 2005年第10期744-746,共3页 China Journal of Chinese Materia Medica
  • 相关文献

参考文献2

二级参考文献17

  • 1王永清,王树春,于立坚,马润娣,郭五保.土贝母甙甲的定量分析方法[J].中国中药杂志,1993,18(6):358-360. 被引量:9
  • 2王永清,姜风良,于立坚,马润娣,陈萍.土贝母甙甲在动物体内的吸收、分布、代谢和排泄[J].中草药,1994,25(5):256-258. 被引量:10
  • 3王永清 于立坚 等.土贝母抗癌有效成分结晶D的临床前药理研究[J].陕西新医药,1984,13:52-53.
  • 4赵学敏.本草纲目拾遗[M].北京:人民卫生出版社,1983.256.
  • 5王永清 于立坚 朱娟莉 等.土贝母提取物抗肿瘤作用的研究[J].陕西新医药,1981,10:55-56.
  • 6Kong F, Zhu D, Xu R, et al. Structural study of tubeimoside 1, a constituent of tu-bei-mo[J]. Tetrahedron Lett, 1986, 27: 5765 -5769.
  • 7Kaisai R, Miyakoshi M, Nie RL, et al. Saponins from Bolbostemma paniculatum: cyclic bisdesmosides, tubeimosides Ⅱ and Ⅲ[J]. Phytochemistry, 1988, 27:1439 - 1446.
  • 8王永清,于立坚.土贝母苷甲注射液稳定性的研究(待发表)
  • 9Yu LJ, Ma RD, Wang YQ, et al. Potent anti-tumor activity and low toxicity of tubeimoside I i,solated from Bolbostemma panicu-latum[J].Plant Med,1994,60:204 208.
  • 10Yu LJ, Ma RD, Yu TX. Induction of morpbological and functional differentiation of human promyelocytic leukemia cells (HL-60)by tubeimoside I [J]. Planta Med, 1996, 62:119- 121.

共引文献80

同被引文献74

引证文献8

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部